GANX (STOCKS)
Gain Therapeutics, Inc. Common Stock
$2.150000
+0.030000 (+1.42%)
Prev close: $2.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gene C. Mack
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $114.47M
- Employees
- 25
- P/E (TTM)
- -4.19
- P/B (TTM)
- 8.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.13 | $-0.14 | +0.0103 | +7.34% |
|
Dec 2025 (Q4)
|
$-0.11 | $-0.15 | +0.0379 | +25.63% |
|
Sep 2025 (Q3)
|
$-0.15 | $-0.15 | +0.0030 | +1.96% |
|
Jun 2025 (Q2)
|
$-0.19 | $-0.17 | -0.0183 | -10.66% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $19.29M |
| Research and Development | $10.10M |
| Other Operating Expenses | $9.19M |
| Operating Income/Loss | -$19.29M |
| Income/Loss From Continuing Operations After Tax | -$20.11M |
| Income/Loss From Continuing Operations Before Tax | -$19.20M |
| Income Tax Expense/Benefit | $906.54K |
| Net Income/Loss | -$20.11M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.11M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.11M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.50 |
| Diluted Earnings Per Share | -$0.50 |
| Basic Average Shares | 121,724,753 |
| Diluted Average Shares | 121,724,753 |
| Assets | $15.42M |
| Current Assets | $14.97M |
| Noncurrent Assets | $452.19K |
| Fixed Assets | $47.03K |
| Other Non-current Assets | $405.17K |
| Liabilities | $4.13M |
| Current Liabilities | $3.43M |
| Accounts Payable | $1.22M |
| Other Current Liabilities | $2.21M |
| Noncurrent Liabilities | $696.04K |
| Long-term Debt | $343.69K |
| Other Non-current Liabilities | $352.36K |
| Equity | $11.29M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.29M |
| Liabilities And Equity | $15.42M |
| Net Cash Flow From Operating Activities | -$18.95M |
| Net Cash Flow From Operating Activities, Continuing | -$18.95M |
| Net Cash Flow From Investing Activities | -$6.39M |
| Net Cash Flow From Investing Activities, Continuing | -$6.40M |
| Net Cash Flow From Financing Activities | $25.35M |
| Net Cash Flow From Financing Activities, Continuing | $25.35M |
| Exchange Gains/Losses | -$12.62K |
| Net Cash Flow | $12.62K |
| Net Cash Flow, Continuing | $25.23K |
| Comprehensive Income/Loss | -$19.69M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.69M |
| Other Comprehensive Income/Loss | -$9.54M |
| Other Comprehensive Income/Loss Attributable To Parent | $419.67K |